These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11011847)

  • 1. Homocysteine and venous thrombosis: outline of a vitamin intervention trial.
    Willems HP; den Heijer M; Bos GM
    Semin Thromb Hemost; 2000; 26(3):297-304. PubMed ID: 11011847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.
    den Heijer M; Willems HP; Blom HJ; Gerrits WB; Cattaneo M; Eichinger S; Rosendaal FR; Bos GM
    Blood; 2007 Jan; 109(1):139-44. PubMed ID: 16960155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.
    Ray JG; Kearon C; Yi Q; Sheridan P; Lonn E;
    Ann Intern Med; 2007 Jun; 146(11):761-7. PubMed ID: 17470822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperhomocysteinemia as a risk factor for venous thrombosis].
    Willems HP; den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Bos GM
    Ned Tijdschr Geneeskd; 1999 Mar; 143(11):552-6. PubMed ID: 10321272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers.
    den Heijer M; Brouwer IA; Bos GM; Blom HJ; van der Put NM; Spaans AP; Rosendaal FR; Thomas CM; Haak HL; Wijermans PW; Gerrits WB
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):356-61. PubMed ID: 9514403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine and renal disease.
    van Guldener C; Robinson K
    Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia, atherosclerosis and thrombosis.
    Cattaneo M
    Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperhomocysteinemia: from theory and practice in the treatment of thrombophilias].
    Kotel'nikov MV
    Kardiologiia; 2004; 44(10):102-6. PubMed ID: 15477801
    [No Abstract]   [Full Text] [Related]  

  • 10. Summaries for patients. Randomized trial of homocysteine-lowering therapy and risk for venous thromboembolism.
    Ann Intern Med; 2007 Jun; 146(11):I22. PubMed ID: 17470823
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study.
    Jamison RL; Hartigan P; Gaziano JM; Fortmann SP; Goldfarb DS; Haroldson JA; Kaufman J; Lavori P; McCully KS; Robinson K
    Clin Trials; 2004; 1(5):451-60. PubMed ID: 16279283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of hyperhomocysteinaemia in patients with thrombophilia.
    O'Donnell J; Perry DJ
    Expert Opin Pharmacother; 2002 Nov; 3(11):1591-8. PubMed ID: 12437493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
    Yap S; Naughten ER; Wilcken B; Wilcken DE; Boers GH
    Semin Thromb Hemost; 2000; 26(3):335-40. PubMed ID: 11011851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of folic acid combined with vitamin B12 on DVT in patients with homocysteine cerebral infarction.
    Shu XJ; Li ZF; Chang YW; Liu SY; Wang WH
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2538-2544. PubMed ID: 28617530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
    Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
    JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
    Schnyder G; Roffi M; Pin R; Flammer Y; Lange H; Eberli FR; Meier B; Turi ZG; Hess OM
    N Engl J Med; 2001 Nov; 345(22):1593-600. PubMed ID: 11757505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial.
    Woodside JV; Yarnell JW; McMaster D; Young IS; Harmon DL; McCrum EE; Patterson CC; Gey KF; Whitehead AS; Evans A
    Am J Clin Nutr; 1998 May; 67(5):858-66. PubMed ID: 9583842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin requirements for the treatment of hyperhomocysteinemia in humans.
    Ubbink JB; Vermaak WJ; van der Merwe A; Becker PJ; Delport R; Potgieter HC
    J Nutr; 1994 Oct; 124(10):1927-33. PubMed ID: 7931701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
    Wuillemin WA; Solenthaler M
    Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.